National Academies Press: OpenBook

The Children's Vaccine Initiative: Continuing Activities (1995)

Chapter: APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)

« Previous: APPENDIX A: PROMISE AND PROBLEMS . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)
Suggested Citation:"APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×

Appendix B

Involving the U.S. Public and Private Sectors in the CVI

October 25–26, 1994

Wayside Inn

Middletown, VA

FINAL AGENDA

Day 1

7:30

Continental Breakfast

8:00

Welcome and Introductions

Samuel Katz, Steering Committee Member

8:05

The Children’s Vaccine Initiative: Status and Outlook

Ciro de Quadros, Workshop Co-Chair

8:30

The New UNICEF Procurement Strategy

John Gilmartin, UNICEF

9:00

Ensuring Vaccine Sufficiency in the Developing World

Peter Ndumbe, University of Yaounde, Cameroon (did not attend)

Suggested Citation:"APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×

9:15

Discussion

10:00

Break

10:15

Why Greater U.S. Involvement in the CVI is a Good Idea

Roy Widdus, National Vaccine Program Office

10:30

Combination Vaccines: Point of Entry to Developing-World Vaccine Markets

Gordon Douglas, Workshop Co-Chair

10:45

Differential Pricing: A History and Look to the Future

William Hubbard, Steering Committee Member

Tim Westmoreland, U.S. Congress

11:15

Discussion

12:00

Lunch and Free Time

3:00

BREAK-OUT GROUPS CONVENE

5:00

Break

5:15

BREAK-OUT GROUPS REPORT

6:15

General Discussion

7:15

Adjourn

8:00

Workshop Dinner (at the Wayside Inn)

Involving the U.S. Public and Private Sectors in the CVI
Day 2

7:00

Continental Breakfast

7:30

Nonvaccine Technology Transfer: Case Studies

Contraceptives: Jeff Spieler, USAID

Agriculture and Animal Vaccines: Judith Chambers, USAID

Suggested Citation:"APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×

8:00

Joint Ventures Between Developed- and Developing-Country Vaccine Makers

Dennis Stainer, Stainer Associates

8:15

A Model for Technology Transfer to the Developing World

George Siber, Massachusetts Department of Health

8:30

Discussion

9:30

Break

9:45

BREAK-OUT GROUPS CONVENE

11:00

Break

11:15

BREAK-OUT GROUPS REPORT

12:00

General Discussion

1:00

Closing Comments

Caroline Hall, Steering Committee Chair

1:15

Adjournment and Lunch

WORKSHOP SPEAKERS

Judith Chambers, Ph.D., Biotechnology Specialist, Office of Agriculture and Food Security, Agency for International Development, Washington, DC

Ciro de Quadros, M.D., M.P.H. (Steering Committee Member), Senior Advisor on Immunization, Pan American Health Organization, Washington, DC

R. Gordon Douglas, Jr., M.D. (Steering Committee Member), President, Merck Vaccine Division, Whitehouse Station, NJ

John Gilmartin, Chief, Purchasing, EPI, UNICEF Supply Division, Copenhagen, Denmark

Caroline Breese Hall, M.D. (Steering Committee Chair), Professor of Pediatrics and Medicine in Infectious Disease, University of Rochester, School of Medicine and Dentistry, Rochester, NY

William N. Hubbard, Jr., M.D. (Steering Committee Member), Hickory Corners, MI

Samuel L. Katz, M.D. (Steering Committee Member), Wilburt C. Davison Professor, Department of Pediatrics, Duke University Medical Center, Durham, NC

Suggested Citation:"APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×

George Siber, M.D., Director, Biologics Laboratory, Massachusetts Department of Health, Jamaica Plain, MA

Jeff Spieler, Chief, Research Division, Office of Population, Agency for International Development, Washington, DC

Dennis W. Stainer, President, Stainer Associates, Ontario, Canada

Timothy M. Westmoreland Esq., Majority Counsel, Subcommittee on Health and the Environment, House Energy and Commerce Committee, Washington, DC

Roy Widdus, Ph.D., Office of the Assistant Secretary for Health, National Vaccine Program Office, Rockville, MD

COMMISSIONED PAPER

“Technology Transfer: Lessons Learned—Vaccines, Contraceptives, and Plants” by Richard T. Mahoney, Ph.D., Vice President and Senior Advisor, Office of the President, Program for Appropriate Technology in Health, Seattle, WA

WORKSHOP PARTICIPANTS

Luis A.V. Barreto, M.D., Assistant Vice President, Clinical and Medical Affairs, Connaught Laboratories, Ltd., Ontario, Canada

Francis R. Cano, Ph.D., President, Aviron, Burlingame, CA

Jose F. Cordero, M.D., M.P.H., Deputy Director, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA

Peter Evans, Acting Chief, Vaccine Supply and Quality, Global Programme on Vaccines, World Health Organization, Geneva, Switzerland

Lance Gordon, Ph.D., President and Chief Executive Officer, ORAVAX Inc., Cambridge, MA

William Hausdorff, Ph.D., Project Officer, Children’s Vaccine Initiative Project, Agency for International Development, Office of Health and Nutrition, Washington, DC

Donald A. Henderson, M.D., M.P.H., Senior Science Advisor, Office of the Assistant Secretary for Health, U.S. Public Health Service, Baltimore, MD

Wayne Morges, Ph.D., Vice President Manufacturing Operations, Amvax Inc., Beltsville, MD

Robert C. Myers, D.V.M., Chief, Division of Biologic Products, Michigan Department of Public Health, Lansing, MI

William Packer, President, Virus Research Institute Inc., Cambridge, MA

Peter Paradiso, Ph.D., Senior Director of Scientific Affairs, Lederle-Praxis Biologicals, West Henrietta, NY

Suggested Citation:"APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×

Regina Rabinovich, M.D., Assistant Director, Division of Microbiology and Infectious Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD

Jerald C. Sadoff, M.D., Director, Division of Communicable Diseases and Immunology, Walter Reed Army Institute for Research, Washington, DC

Tom Stagnaro, President and Chief Executive Officer, UNIVAX Biologics Inc., Rockville, MD

Beatriz Zurita, London School of Hygiene and Tropical Medicine, University of London, London, England

Staff

Michael Stoto, Director, Division of Health Promotion and Disease Prevention

Kathleen Stratton, Senior Program Officer

Polly Harrison, Program Officer

Greg Pearson, Program Officer

Dee Sutton, Administrative Assistant

Suggested Citation:"APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
This page in the original is blank.
Suggested Citation:"APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 49
Suggested Citation:"APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 50
Suggested Citation:"APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 51
Suggested Citation:"APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 52
Suggested Citation:"APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 53
Suggested Citation:"APPENDIX B: INVOLVING THE U.S. PUBLIC AND PRIVATE SECTORS IN THE CVI . . . (FINAL AGENDA, LIST OF SPEAKERS AND PARTICIPANTS)." Institute of Medicine. 1995. The Children's Vaccine Initiative: Continuing Activities. Washington, DC: The National Academies Press. doi: 10.17226/9103.
×
Page 54
Next: APPENDIX C: ACRONYMS AND ABBREVIATIONS »
The Children's Vaccine Initiative: Continuing Activities Get This Book
×
MyNAP members save 10% online.
Login or Register to save!
  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!